Oncology Analytics

    Comprehensive Oncology
    Benefits Management

    Press Releases

    oncology-analytics-publications-view-page-button-94x83 Oncology Analytics’ Distinguished Academic Advisory Board Grows

    New Members Bring Radiation Oncology and Pathology Expertise

    Oncology Analytics' Distinguished Academic Advisory Board Grows New Members Bring Radiation Oncology and Pathology Expertise Oncology Analytics, Inc., today announced that it has added three new members to its Distinguished Academic Advisory Board. The three new board members include noted pathologist, Jonathan Epstein, MD, and key opinion leaders in radiation therapy, David Raben, MD, and Jay Harris, MD. (more…)....Read more >>

    oncology-analytics-publications-view-page-button-94x83 Oncology Analytics Welcomes New Chief Medical Officer

    Board-certified Radiation Oncologist to Spearhead Cancer Benefit Management Initiatives

    Oncology Analytics Welcomes New Chief Medical Officer Board-certified Radiation Oncologist to Spearhead Cancer Benefit Management Initiatives This past June, Richard Wilder, MD, MBA, joined Oncology Analytics as its Chief Medical Officer. Recently, Dr. Wilder served for 2 ½ years as interim chair of the Department of Radiation Oncology at Moffitt Cancer Center in Tampa, Florida. (more…)....Read more >>

    oncology-analytics-publications-view-page-button-94x83 Oncology Analytics Launches MATIS™ Clinical Decision Support Software

    New Centralized and Comprehensive Web-based Application Improves Usability, Efficiency and Productivity in Cancer Care Benefit Management

    Oncology Analytics Launches MATISTM Clinical Decision Support Software New Centralized and Comprehensive Web-based Application Improves Usability, Efficiency and Productivity in Cancer Care Benefit Management Oncology Analytics, Inc., today announced that its MATISTM clinical decision support software has launched, and is actively in use with health care plans and providers throughout the U.S. and Puerto Rico. MATISTM is designed to enhance Oncology Analytics’ evidence-based approach to the evaluation of cancer treatment and benefits management. (more…)....Read more >>